Christopher Macie

Senior Medical Director
HEMA Biologics

Presentation(s):

• PB1174 - Eptacog beta for resolution of bleeding episodes in patients with hemophilia A or B with inhibitors: Efficacy and safety according to inhibitor titer

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1188 - Efficacy and safety of eptacog beta for resolution of spontaneous versus traumatic bleeding episodes in patients with hemophilia A or B with inhibitors

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM